🇺🇸 Recombinant Human Adenovirus Type 5 Injection in United States

Recombinant Human Adenovirus Type 5 Injection (Recombinant Human Adenovirus Type 5 Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Recombinant Human Adenovirus Type 5 Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Recombinant Human Adenovirus Type 5 Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Recombinant Human Adenovirus Type 5 Injection in United States?

Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.